[1]
|
龙俊汕, 张京, 苏小霞, 等. 儿童神经母细胞瘤靶向治疗的研究进展[J]. 临床小儿外科杂志, 2023, 22(7): 619-624.
|
[2]
|
Liu, J., Si, Y., Zhou, Z., et al. (2022) The Prognostic Value of 18F-FDG PET/CT Intra-Tumoural Metabolic Heterogeneity in Pretreatment Neuroblastoma Patients. Cancer Imaging, 22, Article No. 32. https://doi.org/10.1186/s40644-022-00472-4
|
[3]
|
Pinto, N.R., Applebaum, M.A., Volchenboum, S.L., et al. (2015) Advances in Risk Classification and Treatment Strategies for Neuroblastoma. Journal of Clinical Oncology, 33, 3008-3017. https://doi.org/10.1200/JCO.2014.59.4648
|
[4]
|
Nolan, J.C., Frawley, T., Tighe, J., Soh, H., Curtin, C. and Piskareva, O. (2020) Preclinical Models for Neuroblastoma: Advances and Challenges. Cancer Letters, 474, 53-62. https://doi.org/10.1016/j.canlet.2020.01.015
|
[5]
|
Brodeur, G.M. (2018) Spontaneous Regression of Neuroblastoma. Cell and Tissue Research, 372, 277-286. https://doi.org/10.1007/s00441-017-2761-2
|
[6]
|
Feng, L., Li, S., Wang, C. and Yang, J. (2023) Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma. Seminars in Nuclear Medicine, 53, 517-529. https://doi.org/10.1053/j.semnuclmed.2022.12.004
|
[7]
|
Chambers, G., Frood, R., Patel, C. and Scarsbrook, A. (2019) 18F-FDG PET-CT in Paediatric Oncology: Established and Emerging Applications. British Journal of Radiology, 92, Article ID: 20180584. https://doi.org/10.1259/bjr.20180584
|
[8]
|
Howard, B.A. and Wong, T.Z. (2021) 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiologic Clinics, 59, 737-753. https://doi.org/10.1016/j.rcl.2021.06.001
|
[9]
|
Paydary, K., Seraj, S.M., Zadeh, M.Z., et al. (2019) The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer. Molecular Imaging and Biology, 21, 1-10. https://doi.org/10.1007/s11307-018-1181-3
|
[10]
|
Vali, R., Alessio, A., Balza, R., et al. (2021) SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0. Journal of Nuclear Medicine, 62, 99-110. https://doi.org/10.2967/jnumed.120.254110
|
[11]
|
Taggart, D.R., Han, M.M., Quach, A., et al. (2009) Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [18F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response after Iodine-131 MIBG Therapy for Relapsed Neuroblastoma. Journal of Clinical Oncology, 27, 5343-5349. https://doi.org/10.1200/JCO.2008.20.5732
|
[12]
|
Xia, J., Zhang, H., Hu, Q., et al. (2017) Comparison of Diagnosing and Staging Accuracy of PET (CT) and MIBG on Patients with Neuroblastoma: Systemic Review and Meta-Analysis. Current Medical Science, 37, 649-660. https://doi.org/10.1007/s11596-017-1785-x
|
[13]
|
Wang, Y., Xu, Y., Kan, Y., Wang, W. and Yang, J. (2021) Diagnostic Value of Seven Different Imaging Modalities for Patients with Neuroblastic Tumors: A Network Meta-Analysis. Contrast Media & Molecular Imaging, 2021, Article ID: 5333366. https://doi.org/10.1155/2021/5333366
|
[14]
|
Uslu, L., Donig, J., Link, M., Rosenberg, J., Quon, A. and Daldrup-Link, H.E. (2015) Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies. Journal of Nuclear Medicine, 56, 274-286. https://doi.org/10.2967/jnumed.114.146290
|
[15]
|
Choi, Y.J., Hwang, H.S., Kim, H.J., et al. (2014) 18F-FDG PET as a Single Imaging Modality in Pediatric Neuroblastoma: Comparison with Abdomen CT and Bone Scintigraphy. Annals of Nuclear Medicine, 28, 304-313. https://doi.org/10.1007/s12149-014-0813-1
|
[16]
|
Sharp, S.E., Shulkin, B.L., Gelfand, M.J., Salisbury, S. and Furman, W.L. (2009) 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma. Journal of Nuclear Medicine, 50, 1237-1243. https://doi.org/10.2967/jnumed.108.060467
|
[17]
|
Li, H.F., Mao, H.J., Zhao, L., Guo, D.L., Chen, B. and Yang, J.F. (2020) The Diagnostic Accuracy of PET(CT) in Patients with Neuroblastoma: A Meta-Analysis and Systematic Review. Journal of Computer Assisted Tomography, 44, 111-117. https://doi.org/10.1097/RCT.0000000000000973
|
[18]
|
Yağci-Küpeli, B., Koçyiğit-Deveci, E., Adamhasan, F. and Küpeli, S. (2019) The Value of 18F-FDG PET/CT in Detecting Bone Marrow Involvement in Childhood Cancers. Journal of Pediatric Hematology/Oncology, 41, 438-441. https://doi.org/10.1097/MPH.0000000000001499
|
[19]
|
Zapata, C.P., Cuglievan, B., Zapata, C.M., et al. (2018) PET/CT versus Bone Marrow Biopsy in the Initial Evaluation of Bone Marrow Infiltration in Various Pediatric Malignancies. Pediatric Blood & Cancer, 65, e26814. https://doi.org/10.1002/pbc.26814
|
[20]
|
Feng, L., Yang, X., Lu, X., et al. (2022) 18F-FDG PET/CT-Based Radiomics Nomogram Could Predict Bone Marrow Involvement in Pediatric Neuroblastoma. Insights into Imaging, 13, Article No. 144. https://doi.org/10.1186/s13244-022-01283-8
|
[21]
|
Shah, S., Purandare, N., Kembhavi, S., et al. (2022) FDG PETCT for Assessing Marrow Involvement at Staging Pediatric Nonhematological Round Cell Malignancies. Nuclear Medicine Communications, 43, 56-63. https://doi.org/10.1097/MNM.0000000000001491
|
[22]
|
Monclair, T., Brodeur, G.M., Ambros, P.F., et al. (2009) The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report. Journal of Clinical Oncology, 27, 298-303. https://doi.org/10.1200/JCO.2008.16.6876
|
[23]
|
Liu, J., Li, C., Yang, X., et al. (2022) The Diagnostic Value of 18F-FDG PET/CT Bone Marrow Uptake Pattern in Detecting Bone Marrow Involvement in Pediatric Neuroblastoma Patients. Contrast Media & Molecular Imaging, 2022, Article ID: 7556315. https://doi.org/10.1155/2022/7556315
|
[24]
|
Dhull, V.S., Sharma, P., Patel, C., et al. (2015) Diagnostic Value of 18F-FDG PET/CT in Paediatric Neuroblastoma: Comparison with 131I-MIBG Scintigraphy. Nuclear Medicine Communications, 36, 1007-1013. https://doi.org/10.1097/MNM.0000000000000347
|
[25]
|
Ishiguchi, H., Ito, S., Kato, K., et al. (2018) Diagnostic Performance of 18F-FDG PET/CT and Whole-Body Diffusion-Weighted Imaging with Background Body Suppression (DWIBS) in Detection of Lymph Node and Bone Metastases from Pediatric Neuroblastoma. Annals of Nuclear Medicine, 32, 348-362. https://doi.org/10.1007/s12149-018-1254-z
|
[26]
|
Ko, K.Y., Yen, R.F., Ko, C.L., et al. (2022) Prognostic Value of Interim 18F-DOPA and 18F-FDG PET/CT Findings in Stage 3-4 Pediatric Neuroblastoma. Clinical Nuclear Medicine, 47, 21-25. https://doi.org/10.1097/RLU.0000000000003972
|
[27]
|
Sung, A.J., Weiss, B.D., Sharp, S.E., Zhang, B. and Trout, A.T. (2021) Prognostic Significance of Pretreatment F-FDG Positron Emission Tomography/Computed Tomography in Pediatric Neuroblastoma. Pediatric Radiology, 51, 1400-1405. https://doi.org/10.1007/s00247-021-05005-y
|
[28]
|
Qian, L., Yang, S., Zhang, S., et al. (2022) Prediction of MYCN Amplification, 1p and 11q Aberrations in Pediatric Neuroblastoma via Pre-Therapy 18F-FDG PET/CT Radiomics. Frontiers in Medicine, 9, Article 840777. https://doi.org/10.3389/fmed.2022.840777
|
[29]
|
Man, S., Yan, J., Li, J., et al. (2021) Value of Pretreatment 18F-FDG PET/CT in Prognosis and the Reflection of Tumor Burden: A Study in Pediatric Patients with Newly Diagnosed Neuroblastoma. International Journal of Medical Sciences, 18, 1857-1865. https://doi.org/10.7150/ijms.58263
|
[30]
|
Li, C., Zhang, J., Chen, S., et al. (2018) Prognostic Value of Metabolic Indices and Bone Marrow Uptake Pattern on Preoperative 18F-FDG PET/CT in Pediatric Patients with Neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging, 45, 306-315. https://doi.org/10.1007/s00259-017-3851-9
|
[31]
|
中国抗癌协会小儿肿瘤专业委员会, 中华医学会小儿外科学分会肿瘤学组. 儿童神经母细胞瘤诊疗专家共识CCCG-NB-2021方案[J]. 中华小儿外科杂志, 2022, 43(7): 588-598.
|
[32]
|
Wienke, J., Dierselhuis, M.P., Tytgat, G.A.M., Künkele, A., Nierkens, S. and Molenaar, J.J. (2021) The Immune Landscape of Neuroblastoma: Challenges and Opportunities for Novel Therapeutic Strategies in Pediatric Oncology. European Journal of Cancer, 144, 123-150. https://doi.org/10.1016/j.ejca.2020.11.014
|
[33]
|
Kushner, B.H., Yeung, H.W., Larson, S.M., Kramer, K. and Cheung, N.K. (2001) Extending Positron Emission Tomography Scan Utility to High-Risk Neuroblastoma: Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as Sole Imaging Modality in Follow-Up of Patients. Journal of Clinical Oncology, 19, 3397-3405. https://doi.org/10.1200/JCO.2001.19.14.3397
|
[34]
|
Sato, Y., Kurosawa, H., Sakamoto, S., et al. (2015) Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-Cis-Retinoic Acid Treatment for Residual Neuroblastoma after Myeloablative Chemotherapy. Medicine, 94, e1290. https://doi.org/10.1097/MD.0000000000001290
|
[35]
|
Skoura, E., Oikonomopoulos, G., Vasileiou, S., Kyprianou, D., Koumakis, G. and Datseris, I.E. (2014) 18F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP Whole-Body Scans, in Detecting Recurrence of an Adult Adrenal Neuroblastoma. Hellenic Journal of Nuclear Medicine, 17, 58-61.
|
[36]
|
Feng, L., Qian, L., Yang, S., et al. (2022) Clinical Parameters Combined with Radiomics Features of PET/CT Can Predict Recurrence in Patients with High-Risk Pediatric Neuroblastoma. BMC Medical Imaging, 22, Article No. 102. https://doi.org/10.1186/s12880-022-00828-z
|